Risk Factors for Deep Vein Thrombosis After Surgery in Patients with Gastric or Colorectal Cancer Receiving Anticoagulant Prophylaxis

Incidence and risk factors of immediate postoperative deep vein thrombosis in patients undergoing spinal surgery: a retrospective cohort study.

In this cohort, patients with specific baseline characteristics and perioperative factors had a higher likelihood of immediate postoperative distal DVT following spinal surgery, and older age, lower-extremity arterial disease, elevated D-dimer, preoperative walking disability, hypertension, longer operative time, and h...

Risk Factors of Venous Thromboembolism after Colorectal Cancer Surgery

Venous thromboembolism (VTE) is a common and serious complication following colorectal cancer surgery. According to the current data, the incidence of VTE ranges from 0.6 to 26.3%. The data on risk factors for VTE in this cohort of patients are controversial. Objective. To determine the incidence and risk factors for V...

Pattern and prognosis of perioperative deep vein thrombosis after hip fracture: a single-center retrospective cohort study

Purpose Patients undergoing hip fracture surgery are at high risk of deep vein thrombosis (DVT) despite standard prophylaxis due to advanced age, surgery or the fracture itself, and immobilization. We investigated the incidence, pattern, and clinical course of DVT in this population. Methods Consecutive patients who un...

Role of extended venous thromboembolism prophylaxis in patients with colorectal neoplasia who underwent minimally invasive colorectal surgery within an enhanced recovery after surgery protocol.

Prescribing Patterns of Extended Venous Thromboembolism Prophylaxis and VTE Incidence After Colorectal Cancer Resection: Insights From a Single Institution.

INTRODUCTION Patients undergoing colorectal cancer surgery are at increased risk for postoperative venous thromboembolism (VTE). Several societies recommend extended duration pharmacologic prophylaxis after discharge for selected high-risk patients, but real-world use is inconsistent, and the absolute benefit in the er...

Extended venous thromboembolism chemoprophylaxis after pancreas surgery for cancer: Does the subcutaneous needle move the needle?

BACKGROUND Twenty-eight days of extended chemoprophylaxis is recommended for patients undergoing pancreatectomy for malignancy. We hypothesized that the current strategy of extended venous thrombotic event chemoprophylaxis is ineffective in reducing postoperative venous thrombotic events. METHODS This was a single-in...